Connect Biopharma Holdings (CNTB) Retained Earnings (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Retained Earnings of $464.1 million for Q1 2026, up 4.48% sequentially from $444.2 million in Q4 2025, and up 5.4% YoY from $440.3 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Retained Earnings (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Retained Earnings for 7 years, with the latest figure at $464.1 million in Q1 2026.
- Quarterly Retained Earnings rose 5.4% year-over-year to $464.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.1 million (up 5.4% YoY) and the FY2025 annual result came in at $444.2 million, up 1.1% from the prior year.
- Retained Earnings grew to $464.1 million in Q1 2026 per CNTB's latest filing, from $444.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $464.1 million in Q1 2026 and troughed at -$531.7 million in Q2 2024.
- A 5-year average of $113.0 million and a median of $439.4 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings dropped 20.02% in 2022, then jumped 196.85% in 2023.
- Over 5 years, Retained Earnings stood at -$446.4 million in 2022, then surged by 196.85% to $432.4 million in 2023, then grew by 1.61% to $439.4 million in 2024, then rose by 1.1% to $444.2 million in 2025, then rose by 4.48% to $464.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $464.1 million, $444.2 million, and $442.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 465.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 465.51 Mn |
| Mar 31, 2026 | 464.09 Mn |
| Dec 31, 2025 | 444.18 Mn |
| Sep 30, 2025 | 442.54 Mn |
| Jun 30, 2025 | 441.41 Mn |
| Mar 31, 2025 | 440.30 Mn |
| Dec 31, 2024 | 439.36 Mn |
| Jun 30, 2024 | -531.70 Mn |
| Dec 31, 2023 | 432.40 Mn |
| Jun 30, 2023 | -468.76 Mn |
| Dec 31, 2022 | -446.45 Mn |
| Jun 30, 2022 | -414.14 Mn |
| Dec 31, 2021 | -371.97 Mn |
| Dec 31, 2020 | -161.66 Mn |